olopatadine hydrochloride and mometasone furoate
olopatadine hydrochloride and mometasone furoate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Ryaltris. Available dosage form: spray, metered.
Drug Details
- Generic Name
- olopatadine hydrochloride and mometasone furoate
- Brand Names
- Ryaltris
- Application Number
- NDA211746
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 3
- Dosage Forms
- SPRAY, METERED
- Routes
- NASAL
- Active Ingredients
- MOMETASONE FUROATE MONOHYDRATE, OLOPATADINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE RYALTRIS is indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. RYALTRIS is a combination of olopatadine, a histamine-1 (H1)-receptor inhibitor, and mometasone furoate, a corticosteroid, indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. ( 1 )